Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: General Surgical Innovations

This article was originally published in The Gray Sheet

Executive Summary

General Surgical Innovations: Firm gains 510(k) clearance for combination balloon-dissector/tissue-expander instrument for use in plastic and reconstructive surgery procedures. The device combines the firm's proprietary balloon dissector technology with "a traditional tissue expander" to allow "faster and easier tissue expansion procedures," the firm claims. Separately, the Cupertino, California firm reports its Endosaph minimally invasive saphenous vein harvesting system for coronary bypass surgery was used successfully in its first commercial application at the Franciscan Medical Center in Dayton, Ohio. Endosaph was launched last month at the American College of Surgeons meeting in Chicago ("The Gray Sheet" Oct. 20, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009190

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel